cannabis products
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has received approval to commercialize its medical cannabis products in Poland
  • The approval allows Tilray Medical to expand its product offering and distribution across pharmacies in Europe
  • In Poland, Tilray Medical has established multiple partnerships with pharmaceutical companies to distribute both Tilray branded and unbranded medical cannabis products
  • Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis
  • Tilray Brands Inc. (TLRY) is up 1.30 per cent, trading at C$5.46 per share at 1:04 pm ET

Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has received approval to commercialize its medical cannabis products in Poland.

The approval allows Tilray Medical to expand its product offering and distribution across pharmacies in Europe.

Denise Faltischek, Chief Strategy Officer and Head of International Business of Tilray commented on the news.

“I’m extremely proud of our team for once again expanding our approved authorization for Tilray Medical products across Europe. Tilray will continue to advocate for reasonable patient access to reliable and high-quality medical cannabis in Europe and countries around the world.”

Tilray Medical is a leading international provider of EU-GMP certified medical cannabis products in 21 countries. It has a comprehensive portfolio of trusted and reliable THC and CBD products each with a unique profile of cannabinoids and terpenes. 

Tilray Medical has established multiple partnerships with pharmaceutical companies in Poland to distribute Tilray branded and unbranded medical cannabis products. Patients may obtain prescriptions for medical cannabis in Poland through their preferred medical doctor.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 21 countries and across five continents.

Tilray Brands Inc. (TLRY) is up 1.30 per cent, trading at C$5.46 per share at 1:04 pm ET.


More From The Market Herald
Innocan Pharma - CEO Iris Bincovish

" Innocan Pharma (CSE:INNO) patent application for treatment of psoriasis of the scalp goes national

Innocan Pharma’s (INNO) patent application, which claims cannabinoid-based topical compositions can treat psoriasis of the scalp, has reached the national phase.

" Pure Extracts (CSE:PULL) new cured resin vape carts PO from Ontario Cannabis Store

Pure Extracts (PULL) receives a purchase order (PO) from the Ontario Cannabis Store (OCS) for its new, cured resin, 1 g vape carts.

" Decibel (TSXV:DB) announces international expansion of Qwest Brand

Decibel (DB) has secured a supply agreement with Breath of Life International to launch Decibel’s Qwest brand and cannabis products in Israel.

" The BC Bud Corporation (CSE:BCBC) begins trading on the OTCQB

Common shares of The BC Bud Corporation (BCBC) have begun trading on the OTCQB under the symbol WFGCF.